The Supreme Court’s decision to restrict the president’s power to fire Federal Reserve governors has pushed central bank independence back into the spotlight, and dividend investors are paying attention. When interest rate expectations and policy stability are in play, large cap dividend stocks with solid balance sheets can look very different from more speculative income ideas. This article looks at how that ruling and the ongoing tension between the White House and the Fed intersect with dividend resilience, and highlights 3 large cap dividend stocks from the screener that appear positively exposed to this news driven backdrop.

International Business Machines (IBM)

Overview: International Business Machines is a global technology and services company that helps enterprises run critical workloads through its hybrid cloud, AI software, consulting and infrastructure offerings, supported by financing that helps customers acquire its hardware, software and services.

Operations: IBM generates US$30.7b from Software, US$21.3b from Consulting, US$16.2b from Infrastructure and US$0.8b from Financing, with most revenue coming from the Americas (US$34.0b), followed by Europe/Middle East/Africa at US$22.9b and Asia Pacific at US$12.0b.

Market Cap: US$269.0b

IBM stands out in the Large Cap Dividend Stocks screener as a rare combination of long-running dividend reliability, a 2.33% yield and a clear focus on AI, hybrid cloud, chips and quantum computing that many investors are watching closely. Software and consulting are central to this shift, while projects like sub 1 nanometer chips and quantum programs backed by government funding point to potential new engines of demand. At the same time, high debt and exposure to discretionary consulting spend mean the story is not risk free, especially if clients scale back projects or financing costs stay elevated. For investors who care about resilient cash flows in a market that is increasingly priced for AI growth, IBM’s mix of stability and ambition may warrant closer attention.

IBM’s push into AI, hybrid cloud and quantum is gaining attention, but the real story may sit in how its cash flows, debt and dividend profile fit together in the International Business Machines financial health report

Intuit (INTU)

Overview: Intuit is a financial software company behind QuickBooks, TurboTax, Credit Karma and Mailchimp, helping small businesses and consumers manage bookkeeping, payroll, taxes, credit decisions and marketing from a single ecosystem.

Operations: Intuit generates US$12.5b from Global Business Solutions such as QuickBooks and Mailchimp, with total revenue split between the United States at about US$19.3b and International markets at about US$1.7b.

Market Cap: US$73.1b

Intuit attracts income focused investors by pairing rising dividends with a software model built on sticky, recurring cash flows from QuickBooks and TurboTax, now reinforced by Credit Karma and Mailchimp. The company is leaning hard into AI across its platform and expanding upmarket with the Intuit Enterprise Suite and QuickBooks Workforce. It is also returning large sums through buybacks and dividends. At the same time, tax filing policy risk, Mailchimp underperformance and AI competition for TurboTax provide counterbalancing factors for expectations, especially after mixed analyst views and recent rating cuts. For investors watching the Large Cap Dividend Stocks screener, the balance between dependable cash generation, high margins and these emerging risks is where the Intuit story becomes notable.

Intuit’s cash rich, recurring software model and growing AI focus are getting plenty of attention, but most investors still have not unpacked what the analyst forecasts for Intuit hints at for taxes, credit and marketing going forward.

Stryker (SYK)

Overview: Stryker is a medical technology company that supplies hospitals and surgeons with orthopedic implants, surgical and neurotechnology equipment, and advanced tools such as robotic assisted systems, sold to healthcare providers in around 61 countries.

Operations: Stryker generates about US$9.5b from Orthopaedics and US$15.8b from MedSurg and Neurotechnology, with around US$19.0b reported from the United States and a segment adjustment of US$6.2b.

Market Cap: US$120.1b

Stryker may appeal to dividend focused investors because it couples regular dividend growth with exposure to long term trends in aging, chronic disease and minimally invasive procedures, including its Mako robotic platform and recent launches like the Pangea Plating System and TPX HD power tool. Earnings growth has outpaced the wider medical equipment industry. Analysts also expect further revenue and margin expansion, even as the Fed independence ruling keeps rate expectations and funding conditions in sharper focus for leveraged companies. At the same time, a relatively high P/E, elevated debt, insider selling, and regulatory and tariff headwinds mean you need to weigh quality and pricing power against valuation and balance sheet risk to see whether Stryker’s current setup fits your income and growth expectations.

Stryker’s accelerating earnings and robotics story often grab the spotlight, but the real edge may lie in how future procedures and hospital budgets line up with the analyst forecasts for Stryker and one underappreciated risk investors keep missing.

The 3 dividend stocks covered here are only a starting point, and the full Large Cap Dividend Stocks screener surfaces 12 more large caps with dividend strength and financial profiles that line up with equally compelling income narratives. Use Simply Wall St to identify, filter and analyze the specific catalysts, balance sheet traits and dividend patterns that matter most so you can focus on the highest conviction ideas for your portfolio.

Take Control of Your Investment Journey

If Intuit or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Dividends?

Some of the strongest breakouts start quietly, then fly once the crowd finally catches on. Scan these fresh ideas while it still matters and consider them before they become widely followed.

• Target durable income streams while keeping risk in check by scanning a curated mix of resilient companies through the 75 resilient stocks with low risk scores before there is broader interest.
• Spot early momentum in companies building tomorrow’s neural networks as you review the hand picked group of 52 AI infrastructure stocks while they are still under the radar.
• Explore developments in industrial demand by filtering through carefully selected 8 top copper producer stocks before prices change and entry points become less accessible.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.